Study of Aldurazyme® Replacement Therapy in Patients With Mucopolysaccharidosis I (MPS I) Disease

NCT00258011 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

Mucopolysaccharidosis I
Hurler Syndrome
Hurler-Scheie Syndrome
Scheie Syndrome

Interventions

BIOLOGICAL: Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]